Amerigo Scientific Launches Comprehensive AAV Titration ELISA Kits for Accurate, Rapid Gene Therapy Vector Quantification

  • by

— Amerigo Scientific, a trusted provider of critical reagents and assay solutions for life science research, released its expanded portfolio of AAV titration ELISA kits, designed to support precise quantification of adeno‑associated virus (AAV) capsid particles for gene therapy development.

As AAV continues to be one of the most widely applied viral vectors in gene therapy, reliable and consistent measurement of full and empty capsid titers has become essential for research, process development, and quality control. Amerigo Scientific’s ELISA portfolio addresses these needs with robust performance, streamlined workflows, and compliance‑ready design.

Amerigo Scientific offers three complementary product lines to cover diverse research and production requirements:

AAV ELISA Kits: Standard kits for quantitative detection of full and empty AAV capsids, supporting serotypes 1, 2, 3, 5, 6, 8, 9, and rh10. Each kit provides 96 tests per unit.
AAV Xpress ELISA Kits: Accelerated versions for time‑critical applications, delivering results in less than 2 hours while maintaining accuracy and reproducibility. Available for serotypes 2, 5, 6, 8, and 9, with 96 tests per kit.
AAV ELISA Controls: Serotype‑matched positive controls composed of fully assembled empty AAV capsids carrying native conformational epitopes, validated against internal reference standards.

Key Performance Advantages

Reliable Recognition: Proprietary antibodies target native, non‑denatured AAV capsids, enabling accurate quantification of intact viral particles (both full and empty).
High Reproducibility: Low intra‑ and inter‑assay variability, with coefficient of variation (CV) values below 10% for consistent, comparable results.
Traceable Accuracy: AAV2 and AAV8 kits calibrated to ATCC international reference standards; all other serotypes aligned to internal gold‑level references.
GMP‑Ready Design: Validatable for GMP environments and aligned with FDA guidelines supporting AAV gene therapy development and manufacturing.

Amerigo Scientific’s kits employ a sandwich ELISA format using monoclonal antibodies specific for conformational epitopes on assembled AAV capsids. Captured particles are detected in a two‑step process involving biotin‑conjugated antibodies and streptavidin‑peroxidase, producing a colorimetric signal proportional to viral particle concentration.

By enabling precise, scalable AAV titer determination, Amerigo Scientific helps researchers and developers improve vector characterization, optimize production yields, and strengthen quality assurance. The broad serotype coverage and fast‑testing options support projects ranging from early academic studies to clinical‑stage biomanufacturing. For more information about Amerigo Scientific’s AAV titration ELISA kits, including specifications, protocols, and ordering details, please visit the official product page at www.amerigoscientific.com.

About Amerigo Scientific

Amerigo Scientific, as a recognized distributor in the United States, collaborates closely with leading manufacturers worldwide and invites cooperation from all companies and institutions in the area of reagents, kits, antibodies, and many other products for life science, biochemistry, and biotechnology. Its professional team is equipped with excellent technical support and thoughtful customer service. As most of its employees have earned a graduate (Ph.D. or M.S.) degree in life science, they can comprehend customers’ questions or concerns and are always ready to provide individualized customer service of high standards.

Contact Info:
Name: Phoebe Davis
Email: Send Email
Organization: Amerigo Scientific
Website: https://www.amerigoscientific.com/

Release ID: 89190293

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.

Leave a Reply

Your email address will not be published.